Clinical Trial Update: Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating radiotherapy with durvalumab before surgical resection for HPV-negative squamous cell carcinoma of the head and neck; the trial is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• IMFINZI (DURVALUMAB)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 1 | Status: COMPLETED